Page 11234..10..»

Archive for the ‘Personalized Medicine’ Category

Personalized Medicine Products Advanced by FDA in 2019 Address Root Causes of Rare Diseases, Offer Expanded Options for Cancer Patients, and Help…

Friday, February 21st, 2020

WASHINGTON, Feb. 21, 2020 /PRNewswire/ --In a report released this morning, the Personalized Medicine Coalition (PMC) explains how 12 personalized treatments and seven diagnostics the U.S. Food and Drug Administration (FDA) approved or cleared in 2019 will improve patient care and make the health system more efficient by addressing root causes of rare diseases, expanding treatment options for cancer patients, and targeting therapies to responder populations

Read More...

US Researchers Provide Holistic Perspective on Extrusion-Based 3D Printing of Personalized Medicine – 3DPrint.com

Friday, February 21st, 2020

US researchers continue ongoing research into 3D printed pharmaceuticals, presenting their unique findings in Polymers for Extrusion-Based 3D Printing of Pharmaceuticals: A Holistic Materials-Process Perspective. While many have predicted that the pharmaceutical industry was perched on the edge of a massive transformation due to the advantages offered by 3D printing, there are still many ongoing studies regarding suitable printers, materials, and critical issues such as the impacts of DIY drugs and more formalized manufacturing.

Read More...

Personalized Medicine Market Worth $3.92 Trillion by 2026 – Insights Into Diagnostics, Medical Care, Nutrition & Wellness, and Therapeutics – P&T…

Friday, February 21st, 2020

DUBLIN, Feb.

Read More...

Jupiter Medical Center and Sylvester Comprehensive Cancer Center, part of the University of Miami Health System, Enter Affiliation to Advance Cancer…

Friday, February 21st, 2020

JUPITER, Fla., Feb.

Read More...

Single-cell Analysis Market Worth $5.6 Billion by 2025 – Exclusive Report by MarketsandMarkets – PRNewswire

Friday, February 21st, 2020

CHICAGO, Feb. 21, 2020 /PRNewswire/ -- According to the new market research report "Single-cell Analysis Marketby Cell Type (Human, Animal, Microbial), Product (Consumables, Instruments), Technique (Flow Cytometry, NGS, PCR, Mass Spectrometry, Microscopy), Application (Research, Medical Application), End User - Global Forecasts to 2025", published by MarketsandMarkets, the Single-cell Analysis Marketis projected to reach USD 5.6 billion by 2025 from USD 2.1 billion in 2019, at a CAGR of 17.8% during the forecast period.

Read More...

High-throughput Technologies in Drug Discovery – Technology Networks

Friday, February 21st, 2020

Bringing new medicines to patients struggling with serious illness is the driving force behind drug discovery and development. Originating as small molecules, drugs have shifted to large molecule therapies and will continue to shift as precision medicine is adopted. In spite of these different types of drugs, the development time to create them has not changed dramatically

Read More...

Detailed Map of Breast Cancer Reveals the Effects of Mutations on the Tumor Landscape – Clinical OMICs News

Friday, February 21st, 2020

An international team of scientists, spearheaded by a 20 million ($25.9 million) award from Cancer Research UK, has developed the most detailed maps of breast cancer available, which map breast tumor samples to a resolution smaller than a single cell. The maps, published in Nature Cancer this week, detail the intricacies and complexity of the cancer landscapecomprising cancer cells, immune cells, and connective tissueand how it varies both between, and within, tumors depending on their unique genetic makeup

Read More...

PRECISION MEDICINE MARKET 2020: INDUSTRY ANALYSIS AND DETAILED PROFILES OF TOP INDUSTRY PLAYERS ARE NEON THERAPEUTICS, MODERNA, INC, MERCK & CO.,…

Friday, February 21st, 2020

Global Precision Medicine Marketto grow with a substantial CAGR in the forecast period of 2019-2026. Growing prevalence of cancer worldwide and accelerating demand of novel therapies to prevent of cancer related disorders are the key factors for lucrative growth of market Key Market Players: Few of the major competitors currently working in the global precision medicine market are Neon Therapeutics, Moderna, Inc, Merck & Co., Inc, Bayer AG, PERSONALIS INC, GENOCEA BIOSCIENCES, INC., F.

Read More...

Why Companies Need GxP for their Digital Transformation Projects Now, Upcoming Webinar Hosted by Xtalks – PR Web

Friday, February 21st, 2020

Xtalks Life Science Webinars TORONTO (PRWEB) February 21, 2020 Pharmaceutical manufacturers are under increasing pressure to fast-track technological innovation to improve their manufacturing operations in order to adapt to new approaches like Industry 4.0 and continuous manufacturing, combat the growing and intense competition and keep up with the increasing demand for personalized medicine and therapies. But with an industry with the worlds tightest regulations and complex value chains, what are the correct steps to reaching operational intelligence in a GxP compliant manner with end-to-end data integrity

Read More...

Doctors team up with students to improve cervical cancer treatment – Baylor College of Medicine News

Friday, February 14th, 2020

For women with advanced cases of cervical cancer, radiation therapy is generally the only curative treatment.

Read More...

Life Sciences Jobs Expected to Grow by 133,000 Over Next 10 Years in the UK – BioSpace

Friday, February 14th, 2020

Are you in the United Kingdom and looking for a job in the life sciences? Or, are you planning on having a career in the life sciences

Read More...

AI IN MEDICAL DIAGNOSIS: How top US health systems are reacting to the disruptive force of AI by revolutionizi – Business Insider India

Friday, February 14th, 2020

AI is rocking medical diagnosis with its potential to incite drastic improvements to hospital processes. AI can process images and patient health records with more accuracy and expediency than humans are capable of, lessening physician workload, reducing misdiagnosis, and empowering clinical staff to provide more value

Read More...

North American Prostate Cancer Market scrutinized in the new analysis – WhaTech Technology and Markets News

Friday, February 14th, 2020

North American Prostate Cancer Diagnostics and Therapeutics Market Size, Share & Trends Analysis Report by Diagnostic Technique (Prostate-Specific Antigen Test, Digital Rectal Examination, Prostate Biopsy, Imaging Techniques) by Therapeutics (Hormonal Therapy, Chemotherapy, Immunotherapy, Radiation Therapy, Targeted Therapy, Surgery) and Forecast 2019-2025 North American prostate cancer diagnostics and therapeutics market is expected to grow at a CAGR of 10.4% during the forecast period.

Read More...

In-Vitro Toxicology/Toxicity Testing Market Trends, 2019-2024 – Increasing Focus on Drug Discovery and Personalized Medicine Using In Vitro Methods -…

Wednesday, February 12th, 2020

Dublin, Feb. 12, 2020 (GLOBE NEWSWIRE) -- The "In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024" report has been added to ResearchAndMarkets.com's offering.

Read More...

Growing Biomedical Research and Focus on Personalized Medicine to Aid Cell Isolation Market available in the latest report – WhaTech

Wednesday, February 12th, 2020

Global cell isolation market is expected to attain a CAGR of 18.8% during the forecast period. The global cell isolation market accounted for $4.6 billion revenue in 2017, and it is expected to attain a CAGR of 18.8% during the forecast period (20182023)

Read More...

A team of scientists examined more than 2600 cancer genomes. Here’s what they found. – The Daily Briefing

Wednesday, February 12th, 2020

A team of international clinicians and scientists on Wednesday published findings from a comprehensive review of more than 2,600 cancer genomes, which observers say could further pave the way for clinicians to prescribe precise treatments to cancer patients based on their genes. The team, who published their findings in 23 papers in Nature and its affiliated journals, completed the research through a joint project of the International Cancer Genome Consortium (ICGC) and U.S.-funded Cancer Genome Atlas (TCGA) called the Pan-Cancer Analysis of Whole Genomes Project (PCAWG)

Read More...

Personalized Medicine Market 2020 Booming by Size, Revenue, Trend and Top Companies 2026 – Instant Tech News

Wednesday, February 12th, 2020

New Jersey, United States, The report titled, Personalized Medicine Market Size and Forecast 2026 in Verified Market Research offers its latest report on the global Personalized Medicine market that includes comprehensive analysis on a range of subjects like competition, segmentation, regional expansion, and market dynamics. The report sheds light on future trends, key opportunities, top regions, leading segments, the competitive landscape, and several other aspects of the Personalized Medicine market. Get access to crucial market information

Read More...

Study Shows That Caris Life Sciences’ ADAPT Biotargeting System Has Discovered Protein Expression Pattern Differences Between Two Prostate Cancer…

Wednesday, February 12th, 2020

First time findings published in Nucleic Acids Research demonstrate the ability to differentiate exosomes from cancer cell subtypes from the same tumor type offering broad potential applications in biomarker discovery IRVING, Texas, Feb. 12, 2020 /PRNewswire/ -- Caris Life Sciences, a leading innovator in molecular science focused on fulfilling the promise of precision medicine, today announced the publication of new data in Nucleic Acids Research,illustrating that use of the Company's proprietary ADAPT Biotargeting System can lead to the identification of differences in protein expression patterns between exosomes from two related prostate cancer cell lines, vertebral cancer of the prostate (VCaP) and lymph node cancer of the prostate (LNCaP). Caris Life Sciences Logo (PRNewsfoto/Caris Life Sciences) The paper, "ADAPT identifies an ESCRT complex composition that discriminates VCaP from LNCaP prostate cancer cell exosomes," also demonstrates that the ADAPT platform can be a powerful method that allows for the enrichment of polyligands that can distinguish even between different subpopulations of the same disease.

Read More...

Precision Medicine is Focus of Genedata, Crohn’s Foundation Project – IBD News Today

Wednesday, February 12th, 2020

Genedata and the Crohns & Colitis Foundation completed a project aimed at advancing precision care for Crohns disease patients.Genedata, a biopharmaceutical research and development software company, worked with foundation investigators and clinicians to integrate and study multi-omic and clinical data culled from patients with Crohns, which, along with ulcerative colitis, is among the most common forms of inflammatory bowel disease (IBD).The data will be used to identify the biomarkers that can be the most useful in evaluating, within five years of IBD diagnosis, a person's risk of developing disease complications that require surgery.Crohns disease is a chronic, often debilitating disease, for which there is currently no cure, Andres Hurtado-Lorenzo, PhD, the foundations senior director of translational research, said in a press release. Despite several treatment options, currently we lack predictive tests to determine the optimal treatment strategy early in the disease process, when the opportunity to improve outcomes is greatest.""There is a significant unmet need to advance new diagnostic tools to enable precision medicine approaches and to optimize patient care according to the severity of the disease course," he said.The foundation sought help with leveraging abundant clinical and molecular data

Read More...

Brooks Bell: ‘Groundbreaking blood test determined there is 95% chance my cancer is gone and won’t return’ – WRAL Tech Wire

Wednesday, February 12th, 2020

Editors note:Brooks Bell is the founder and CEO of her eponymous brand consulting firm. RALEIGH A year ago, I was diagnosed with stage 3 colon cancer. Its been a tough year: 6 months of surgery and chemotherapy, followed by intense health recovery.

Read More...

Page 11234..10..»


2020 © StemCell Therapy is proudly powered by WordPress
Entries (RSS) Comments (RSS) | Violinesth by Patrick